Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | METAP1 | P53582 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7621061 | 0.94 | LMNA (0.64) | LMNATSHRALDH1A1METAP1ADRA1A | |
| SCHEMBL7145506 | 0.94 | LMNA (0.64) | LMNATSHRALDH1A1METAP1ADRA1A | |
| SCHEMBL1614926 | 0.91 | LMNA (0.57) | LMNATSHRALDH1A1METAP1ADRA1A | |
| SCHEMBL3082026 | 0.88 | LMNA (0.55) | LMNATSHRALDH1A1METAP1ADRA1A | |
| SCHEMBL1554454 | 0.87 | LMNA (0.56) | LMNATSHRALDH1A1METAP1 | |
| SCHEMBL4754377 | 0.84 | LMNA (0.55) | LMNATSHRALDH1A1ADRA1ATDP1 | |
| SCHEMBL45286 | 0.84 | LMNA (0.55) | LMNATSHRALDH1A1ADRA1ATDP1 | |
| SCHEMBL1614593 | 0.83 | ALDH1A1 (0.54) | LMNATSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL4276778 | 0.82 | LMNA (0.50) | LMNATSHRALDH1A1ADRA1ATDP1 | |
| SCHEMBL2335709 | 0.82 | LMNA (0.50) | LMNATSHRALDH1A1METAP1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115298262-A | Inorganic filler dispersion stabilizer, inorganic filler-containing resin composition, molded article, and additive | DIC株式会社 | 2022-11-04 | — | — | CN | disclosed |
| US-20220033335-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| US-20220033334-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2022-02-03 | — | — | US | disclosed |
| EP-3889126-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | Maruzen Petrochemical Co., Ltd. (JP) | 2021-10-06 | — | — | EP | disclosed |
| EP-3889125-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | Maruzen Petrochemical Co., Ltd. (JP) | 2021-10-06 | — | — | EP | disclosed |
| CN-113166016-A | Method for producing divinyl ether compound having alkylene skeleton | 丸善石油化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-113166015-A | Method for producing divinyl ether compound having alkylene skeleton | 丸善石油化学株式会社 | 2021-07-23 | — | — | CN | disclosed |
| US-20110086975-A1 | COLORED GEL COAT COMPOSITION AND ARTICLE | VALSPAR SOURCING, INC. | 2011-04-14 | — | — | US | disclosed |
| EP-0807617-B1 | PROCESS FOR PREPARING 1,5-PENTANEDIOL DERIVATIVE | KYOWA YUKA KK (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-6072089-A | REACTING 2-BUTENAL DERIVATIVE WITH FORMALDEHYDE, HYDROGENATING MIXTURE OF PRODUCTS WITHOUT SEPARATING | KYOWA YUKA CO., LTD. (JP) | 2000-06-06 | — | — | US | disclosed |
| EP-0807617-A1 | PROCESS FOR PREPARING 1,5-PENTANEDIOL DERIVATIVE | Kyowa Yuka Co., Ltd. (JP) | 1997-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033334-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | DECR2, KAT8, DECR1 | LMNA 215/4885TSHR 3684/4885ALDH1A1 2263/4885 |
| US-20220033335-A1 | METHOD FOR PRODUCING DIVINYL ETHER COMPOUND HAVING ALKYLENE SKELETON | DECR2, DECR1, ACMSD | LMNA 657/4885TSHR 3362/4885ALDH1A1 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.